Clinical Trial Update: Quantitative Imaging Metrics From CECT in Measuring Disease Response or Progression in Patients With Kidney Cancer

View source ↗

Summary

This completed clinical trial investigates quantitative imaging metrics from contrast-enhanced CT (CECT) to measure disease response or progression in renal cel…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: University of Southern California | Conditions: Renal Cell Carcinoma | Status: COMPLETED